Similar companies
Related EMIS Industry Reports
The company is a science and technology pharmaceutical enterprise mainly engaged in the R&D, production and sales of anti-infection drugs, 10 products with new drug certificate, 272 drug approval numbers. The company at present has strong competitiveness in a new generation of penicillin field. The main products are the injectable mezlocillin sodium sulbactam sodium, injectable amoxilin sodium sulbactam sodium, amoxicillin clavulanic potassium piece, injectable amoxilin clavulanic potassium, injectable mezlocillin sodium, aztreonam for inj, metronidazole phosphoric acid two sodium for inj, etc. The injectable amoxicillin sodium sulbactam sodium and metronidazole phosphoric acid two sodium for inj are the domestic first listed new drug varieties, the aztreonam for inj is domestic first copy drugs approved.
Headquarters
No. 1378, Hengan Street, Economic and Technological Development Zone, Datong City, Shanxi Province
Datong; Shanxi;
Postal Code: 037010
Contact Details: Purchase the Shanxi C&Y Pharmaceutical Group Co.,Ltd. report to view the information.
Website: http://www.cy-pharm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service